A peer support intervention in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT): The STEPP randomized pilot trial design and methods outline.

IF 2 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Emma P Keane, Michelle Guo, Lisa M Gudenkauf, Annabella C Boardman, M Tim Song, Emma D Wolfe, Isabella S Larizza, Manfred N Mate-Kole, Brian C Healy, Jeff C Huffman, Areej El-Jawahri, Hermioni L Amonoo
{"title":"A peer support intervention in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT): The STEPP randomized pilot trial design and methods outline.","authors":"Emma P Keane, Michelle Guo, Lisa M Gudenkauf, Annabella C Boardman, M Tim Song, Emma D Wolfe, Isabella S Larizza, Manfred N Mate-Kole, Brian C Healy, Jeff C Huffman, Areej El-Jawahri, Hermioni L Amonoo","doi":"10.1016/j.cct.2024.107746","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Despite the association between peer support interventions and improved patient-reported outcomes (PROs) across cancer populations, there is a lack of structured peer support interventions for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT).</p><p><strong>Objective: </strong>To test the feasibility, acceptability, and preliminary efficacy of a novel five-session, phone-delivered peer support intervention (STEPP: Supporting Transplant Experiences with Peer Program) for improving quality of life (QOL) and reducing psychological distress in patients undergoing HSCT.</p><p><strong>Methods: </strong>This single-center pilot randomized clinical trial (RCT) will compare the STEPP intervention to usual transplant care among 90 patients hospitalized for HSCT. Eligible participants include adults (age ≥ 18 years) with hematologic malignancies hospitalized for autologous or allogeneic HSCT. The STEPP intervention provides informational, emotional, and practical support. To test the primary aim of intervention feasibility, we have established a priori benchmarks of 60 % enrollment of eligible patients and 60 % completion of at least 3 out of 5 intervention sessions among those randomized to STEPP. Acceptability will be assessed using the Client Satisfaction Questionnaire, with scores ≥3.0/4.0 indicating greater intervention acceptability. To test the secondary aim of preliminary efficacy, we will examine changes in PROs (e.g., anxiety symptoms and QOL) from pre- to post-intervention.</p><p><strong>Discussion: </strong>This pilot RCT of a structured, phone-delivered peer support intervention tailored to the needs of patients preparing to undergo HSCT will elucidate the feasibility, acceptability, and preliminary efficacy of the STEPP intervention. We will then be poised to conduct a future, full-scale RCT to establish the efficacy of STEPP on patient outcomes.</p><p><strong>Clinicaltrials: </strong>gov: NCT06010017.</p>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":" ","pages":"107746"},"PeriodicalIF":2.0000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cct.2024.107746","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Despite the association between peer support interventions and improved patient-reported outcomes (PROs) across cancer populations, there is a lack of structured peer support interventions for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT).

Objective: To test the feasibility, acceptability, and preliminary efficacy of a novel five-session, phone-delivered peer support intervention (STEPP: Supporting Transplant Experiences with Peer Program) for improving quality of life (QOL) and reducing psychological distress in patients undergoing HSCT.

Methods: This single-center pilot randomized clinical trial (RCT) will compare the STEPP intervention to usual transplant care among 90 patients hospitalized for HSCT. Eligible participants include adults (age ≥ 18 years) with hematologic malignancies hospitalized for autologous or allogeneic HSCT. The STEPP intervention provides informational, emotional, and practical support. To test the primary aim of intervention feasibility, we have established a priori benchmarks of 60 % enrollment of eligible patients and 60 % completion of at least 3 out of 5 intervention sessions among those randomized to STEPP. Acceptability will be assessed using the Client Satisfaction Questionnaire, with scores ≥3.0/4.0 indicating greater intervention acceptability. To test the secondary aim of preliminary efficacy, we will examine changes in PROs (e.g., anxiety symptoms and QOL) from pre- to post-intervention.

Discussion: This pilot RCT of a structured, phone-delivered peer support intervention tailored to the needs of patients preparing to undergo HSCT will elucidate the feasibility, acceptability, and preliminary efficacy of the STEPP intervention. We will then be poised to conduct a future, full-scale RCT to establish the efficacy of STEPP on patient outcomes.

Clinicaltrials: gov: NCT06010017.

对接受造血干细胞移植(HSCT)的血液恶性肿瘤患者进行同伴支持干预:STEPP 随机试验设计与方法概要。
背景:尽管在癌症人群中,同伴支持干预与患者报告结果(PROs)的改善之间存在关联,但对于接受造血干细胞移植(HSCT)的血液恶性肿瘤患者而言,缺乏结构化的同伴支持干预:目的:测试一项为期五次、通过电话提供的新型同伴支持干预(STEPP:Supping Transplant Experiences with Peer Program)的可行性、可接受性和初步疗效,以改善造血干细胞移植患者的生活质量(QOL)并减轻其心理压力:这项单中心试点随机临床试验(RCT)将在 90 名住院接受造血干细胞移植的患者中比较 STEPP 干预与常规移植护理。符合条件的参与者包括住院接受自体或异体造血干细胞移植的血液恶性肿瘤成人患者(年龄≥ 18 岁)。STEPP 干预方案提供信息、情感和实际支持。为了检验干预措施的可行性这一首要目标,我们事先设定了一个基准,即符合条件的患者中有 60% 加入 STEPP,随机接受 STEPP 治疗的患者中有 60% 至少完成了 5 个干预疗程中的 3 个疗程。可接受性将使用客户满意度问卷进行评估,得分≥3.0/4.0 表示干预可接受性更高。为了检验初步疗效这一次要目标,我们将检查从干预前到干预后PROs(如焦虑症状和QOL)的变化:这项针对准备接受造血干细胞移植的患者的需求量身定制的结构化、通过电话提供的同伴支持干预试点 RCT 将阐明 STEPP 干预的可行性、可接受性和初步疗效。然后,我们将准备在未来开展一项全面的 RCT,以确定 STEPP 对患者预后的疗效:NCT06010017。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
4.50%
发文量
281
审稿时长
44 days
期刊介绍: Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信